Nirav N. Shah

Also affiliated with Johnson & Johnson (India)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial”.

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

Blood(2020)10.1182/blood.2020004823

N/A

7.0DataRank · unranked

307 citations

Miguel‐Angel Perales, Mark A. Schroeder, Haris Ali, Nirav N. Shah, Yi‐Bin Chen +8 more

Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL: the phase 1b BRUIN trial

Blood(2024)10.1182/blood.2024024510

N/A

0.874DataRank · unranked

27 citations

Jennifer A. Woyach, Chan Y. Cheah, Catherine C. Coombs, Nirav N. Shah, William G. Wierda +13 more

Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy

Communications Medicine(2022)10.1038/s43856-022-00116-5

N/A

0.616DataRank · unranked

16 citations

Anikó Szabó, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett +11 more

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

Blood(2025)10.1182/blood.2024027009

N/A

0.452DataRank · unranked

6 citations

Bastien Nguyen, Sai Prasad Desikan, Helen Won, Shady I. Tantawy, Samuel McNeely +22 more

Methods developed during the first National Center for Biotechnology Information Structural Variation Codeathon at Baylor College of Medicine

F1000Research(2020)10.12688/f1000research.23773.1

N/A

0DataRank · unranked

0 citations

Alejandro R. Gener, Michael M. Khayat, Adam C. English, Advait Balaji, Anbo Zhou +41 more

Epigenome editing of the CFTR-locus for treatment of cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.04.008

N/A

0DataRank · unranked

14 citations

Leah Machlin, Nikita Dalal, Rhianna E. Lee, Ian C. McDowell, Nirav N. Shah +4 more

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.006

N/A

0DataRank · unranked

312 citations

Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed +26 more

Barriers to delirium screening and management during hospital admission: a qualitative analysis of inpatient nursing perspectives

BMC Health Services Research(2023)10.1186/s12913-023-09681-4

N/A

0DataRank · unranked

42 citations

Alexandra Norcott, Lakeshia Benn, Nirav N. Shah, Amy McKinney, Lillian Min +2 more

Trial in Progress: A Phase 1b Study of AS-1763, an Oral, Potent and Selective Noncovalent BTK Inhibitor, in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Blood(2023)10.1182/blood-2023-182568

N/A

0DataRank · unranked

1 citations

James D’Olimpio, Andew gillis-Smith, Seung‐Tae Lee, Nirav N. Shah, Javier Pinilla‐Ibarz +9 more

Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study

Blood(2023)10.1182/blood-2023-186145

N/A

0DataRank · unranked

0 citations

Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Lindsey E. Roeker, Krish Patel +17 more

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Haematologica(2024)10.3324/haematol.2024.285754

N/A

0DataRank · unranked

13 citations

Michael Wang, Lindsey E. Roeker, Krish Patel, Jennifer A. Woyach, William G. Wierda +30 more

Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies

Acta Haematologica(2024)10.1159/000539587

N/A

0DataRank · unranked

1 citations

Catherine C. Coombs, Nirav N. Shah, Wojciech Jurczak, Jennifer A. Woyach, Chan Y. Cheah +16 more

Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects

medRxiv(2024)10.1101/2024.03.13.24303864

N/A

0DataRank · unranked

173 citations

Rahul Gupta, Masahiro Kanai, Wenhan Lu, Kristin Tsuo, Ying Wang +24 more

Epigenome editing of the CFTR-locus for treatment of cystic fibrosis

UNC Libraries(2024)10.17615/03pd-yq57

N/A

0DataRank · unranked

0 citations

Timothy E. Reddy, Ami M. Kabadi, Lauren Drowley, Navneet Dalal, I.F.W. McDowell +4 more

Extending Genome-Wide Association Studies to admixed cohorts with high degrees of relatedness

medRxiv(2025)10.1101/2025.05.27.25328444

N/A

0DataRank · unranked

0 citations

Alejandra Vergara-Lope, José Jaime Martínez‐Magaña, Nirav N. Shah, Kai Yuan, Jaime Berúmen +9 more

Tractor Workflow Pipeline: A Scalable Nextflow Framework for Local Ancestry-Aware Genome-Wide Association Studies

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.02.673402

N/A

0DataRank · unranked

0 citations

Taotao Tan, Jessica Honorato‐Mauer, Yi-Sian Lin, Adam X. Maihofer, Clement C. Zai +5 more

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Blood Advances(2020)10.1182/bloodadvances.2020001956

N/A

0DataRank · unranked

86 citations

Peter Dreger, Jennifer R. Brown, Oscar Lahoud, Toby A. Eyre, Danielle M. Brander +20 more

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Blood Advances(2020)10.1182/bloodadvances.2019001266

N/A

0DataRank · unranked

36 citations

Rajneesh Nath, Jan Černý, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel‐Azim +80 more

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Blood Advances(2020)10.1182/bloodadvances.2019000765

N/A

0DataRank · unranked

51 citations

J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza +9 more